This report is being filed on an international product list 08p32-20, that has a similar us product distributed in the us, list 08p32-21 and 08p32-31.Patient information: no further information is available.Investigation of the customer issue included a review of the complaint text, a search for similar complaints, in-house testing and a review of labeling.Review of tracking and trending reports for the alinity i ca 19-9xr assay did not identify any related trends.An increase in complaint activity associated with the complaint issue was identified for reagent lot 98368fp00.Return testing was not completed as returns were not available.An internal panel was tested with retained kits of reagent lot 98368fp00.Acceptance criteria was met, which indicates acceptable product performance.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the alinity i ca 19-9xr assay was identified.
|